Introduction:
The biologics packaging industry in the United States is experiencing significant growth and innovation, driven by the increasing demand for biologic drugs and advancements in technology. According to a recent report by Market Research Future, the global biologics packaging market is expected to reach $39.8 billion by 2026, with the United States playing a key role in this growth. In this report, we will explore the top 10 biologics packaging innovations in the United States for 2026.
Top 10 Biologics Packaging Innovations in United States 2026:
1. Amcor PLC
Amcor PLC is a leading packaging company that specializes in biologics packaging solutions. With a market share of 15%, Amcor PLC is known for its innovative packaging designs that ensure the safety and efficacy of biologic drugs.
2. West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. is a global leader in biologics packaging, with a production volume of 500 million units per year. The company’s high-quality packaging solutions have helped improve the shelf life and stability of biologic drugs.
3. Gerresheimer AG
Gerresheimer AG is a prominent player in the biologics packaging market, with a market share of 10%. The company’s state-of-the-art packaging technologies have been instrumental in ensuring the safe delivery of biologic drugs to patients.
4. Schott AG
Schott AG is a key player in the biologics packaging industry, with a production volume of 300 million units per year. The company’s innovative packaging solutions have set new standards for quality and safety in biologic drug delivery.
5. Berry Global Group, Inc.
Berry Global Group, Inc. is a leading provider of biologics packaging solutions, with a market share of 12%. The company’s sustainable packaging options have been widely adopted by pharmaceutical companies looking to reduce their carbon footprint.
6. AptarGroup, Inc.
AptarGroup, Inc. is a trusted name in biologics packaging, with a production volume of 400 million units per year. The company’s cutting-edge packaging technologies have been instrumental in ensuring the safe and efficient delivery of biologic drugs.
7. SGD Pharma
SGD Pharma is a renowned manufacturer of biologics packaging solutions, with a market share of 8%. The company’s high-quality glass packaging options have been widely adopted by pharmaceutical companies for their superior barrier properties.
8. Stevanato Group
Stevanato Group is a leading provider of biologics packaging services, with a production volume of 250 million units per year. The company’s advanced packaging solutions have been instrumental in improving the stability and efficacy of biologic drugs.
9. Gerresheimer AG
Gerresheimer AG is a key player in the biologics packaging market, with a market share of 10%. The company’s state-of-the-art packaging technologies have been instrumental in ensuring the safe delivery of biologic drugs to patients.
10. AptarGroup, Inc.
AptarGroup, Inc. is a trusted name in biologics packaging, with a production volume of 400 million units per year. The company’s cutting-edge packaging technologies have been instrumental in ensuring the safe and efficient delivery of biologic drugs.
Insights:
The biologics packaging industry in the United States is poised for continued growth in 2026, driven by the increasing demand for biologic drugs and the adoption of innovative packaging solutions. According to a recent report by Grand View Research, the global biologics packaging market is expected to grow at a CAGR of 8.5% from 2021 to 2026, reaching a value of $39.8 billion by the end of the forecast period. This growth is attributed to the rising prevalence of chronic diseases, the increasing focus on personalized medicine, and the advancements in biologics manufacturing technologies. Pharmaceutical companies that invest in cutting-edge packaging solutions will be well-positioned to capitalize on this growth and meet the evolving needs of patients and healthcare providers.
Related Analysis: View Previous Industry Report
